Surgical biology for the clinician: vascular effects of immunosuppression.
Tepperman
Elissa
E
Division of Cardiovascular Surgery, University Health Network, Toronto, Ont.
Ramzy
Danny
D
Prodger
Jessica
J
Sheshgiri
Rohit
R
Badiwala
Mitesh
M
Ross
Heather
H
Raoa
Vivek
V
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D001379:Azathioprine / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology*; D051799:Delayed Graft Function / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology* / Q000503:physiopathology; D000068338:Everolimus; D006084:Graft Rejection; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D007108:Immune Tolerance / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000494:pharmacology*; D016559:Tacrolimus / Q000494:pharmacology*; D014181:Transplantation Immunology
D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D001379:Azathioprine; D020123:Sirolimus; D016559:Tacrolimus